What happens when your DNA becomes a corporate asset? In this episode of Data Darling, host L.E. Davis dives into the rise and fall of 23andMe, the Silicon Valley darling that promised to unlock the secrets of our genes but left millions of users questioning the fate of their genetic data after its bankruptcy.

We explore:

• The legal and ethical implications of 23andMe’s collapse.

• A groundbreaking Texas custody battle over cryogenically stored embryos (Antoun v. Antoun).

• CoFertility’s controversial egg donation model and its parallels to organ donation.

• Why eHealth startups blur the lines between patient care and profit.

From genetic privacy to reproductive rights, this episode unpacks how our most personal information—our DNA—is being commodified in ways we never imagined. Are we patients, products, or something in between?

🎧 Listen now to learn:

• How to protect your genetic data in a post-23andMe world.

• The hidden risks of signing medical consent forms.

• What laws need to change to safeguard our biological and digital footprints.

👉 Don’t forget to subscribe, share, and leave a review! Let’s keep the conversation going about genetic privacy and human rights.